GlycoMimetics Shares Are Trading Higher After the Company Disclosed That Chief Medical Officer Edwin Rock Bought 305,000 Shares at an Average Price of $0.26 per Share.
GlycoMimetics Shares Are Trading Higher After the Company Disclosed That Chief Medical Officer Edwin Rock Bought 305,000 Shares at an Average Price of $0.26 per Share.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.